-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Turnstone Biologics Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
- Turnstone Biologics Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$816K, a 2373% decline year-over-year.
- Turnstone Biologics Corp. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$963K.
- Turnstone Biologics Corp. annual Income Tax Expense (Benefit) for 2023 was -$286K, a 303% decline from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)